Overview
ELAB market data
Price History
ELAB price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ELAB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
PMGC Holdings’ Unit Executes Standard Exclusive License Agreement with Know-How With FSURF For Certain Patent Rights And Related Know-How Covering Multi-Domain Drone Payload TechnologyBenzinga · Jul 13, 2026, 11:32 AM
Why PMGC Holdings Shares are Surging On Friday?Benzinga · Jul 10, 2026, 3:01 PM
Stock Market Today: Dow Jones, S&P 500 Futures Fall as Investors Await SK Hynix Debut and US Reportedly Mulls ‘Technical Talks’ With Iran— PMGC Holdings, WD-40, Netflix In Focus (UPDATED)Benzinga · Jul 10, 2026, 12:35 PM
NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen ExpressionGlobenewswire Inc · Jul 10, 2026, 12:15 PM
PMGC Unit NorthStrive Biosciences Plans To Initiate An Independent Flow Cytometry Analysis To Further Characterize EL-22, Its Candidate For Preserving Muscle During Weight Loss TreatmentsBenzinga · Jul 10, 2026, 11:40 AM
8-K filing — PMGC Holdings Inc. (ELAB)SEC EDGAR · Jul 9, 2026, 8:01 PM
PMGC Holdings Integrates AGA Precision Systems Into A&B AerospaceBenzinga · Jul 6, 2026, 11:35 AM
NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva BiosciencesGlobenewswire Inc · Jul 1, 2026, 12:15 PM
PMGC Holdings’ Northstrive Biosciences Announces Results From Phase III Of AI-Driven Drug Discovery Program With Strategic Partner Yuva BiosciencesBenzinga · Jul 1, 2026, 11:40 AM
NorthStrive Biosciences Submits Two New U.S. Patents For Its Intellectual Property Portfolio Into Potential Human Pharmaceutical ApplicationsBenzinga · Jun 18, 2026, 11:35 AM